OUR LEADERSHIP

---

Douglas Oliver, MSW has an extensive 20-year career in that field of medical social work, gerontology, and healthcare policy compliance. In 2019, he was awarded a Regenerative Medicine and Stem Cell Action Award For Inspiration at the World Stem Cell Summit. He is described as a "Patient Ambassador", seeking to elevate the Patient Position in direct drug development roles.

Anthony Oliva, PhD is a nationally-recognized leader in  neurosciences, specializing in neurodegenerative diseases and aging. He has served as an assistant professor at the Herbert Wertheim College of Medicine at Florida International University, and as a senior scientist at Longeveron, leading clinical programs in Alzheimer’s disease, Aging Frailty, and other indications. 

Jeff Ervin, MBA carries a proven track record for administration, leadership, and finance. He has a distinguished career, holding positions such as Senior Financial Analyst for the Baptist Hospital System of Nashville, Senior Financial Officer for Medicare.com, and  Co-Founder, President and CEO of IMAC Holdings, a company he took public in 2019.

David RP Almeida, MD, PhD, MBA is a world-renowned retina researcher. As Founder of Erie Retina Research, and CaseX Erie, he has extensive experience conducting numerous FDA clinical trials in the retinal disease space, with a specialty in developing new and innovative methods for drug delivery, including suprachoroidal administration of cell-based therapies.

 Mark A. Kilgore, Ph.D, JD applies his extensive legal and scientific background to high-quality patent prosecution services in the

fields of biotechnology, pharmaceuticals, medical devices, and the mechanical arts, as well as  IP procurement. He also provides counsel in licensing , non-disclosure, and confidentiality agreements.